At the end of the latest market close, BIOLASE Inc. (BIOL) was valued at $0.72. In that particular session, Stock kicked-off at the price of $0.733 while reaching the peak value of $0.74 and lowest value recorded on the day was $0.7041. The stock current value is $0.73.
Recently in News on June 3, 2021, Recent Studies Demonstrate BIOLASE’s Waterlase Laser Technology is Beneficial for Treatment of Peri-Implantitis. Studies published in two journals, International Journal of Periodontics & Restorative Dentistry and Lasers in Medical Science, support use of proprietary Er,Cr:YSGG laser technology for peri-implantitis treatments. You can read further details here
BIOLASE Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $1.5100 on 01/26/21, with the lowest value was $0.3800 for the same time period, recorded on 01/04/21.
BIOLASE Inc. (BIOL) full year performance was -2.73%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, BIOLASE Inc. shares are logging -51.43% during the 52-week period from high price, and 199.35% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.25 and $1.51.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1341715 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the BIOLASE Inc. (BIOL) recorded performance in the market was 72.47%, having the revenues showcasing -17.50% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 109.18M, as it employees total of 135 workers.
BIOLASE Inc. (BIOL) in the eye of market guru’s
During the last month, 0 analysts gave the BIOLASE Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 0.8985, with a change in the price was noted -0.18. In a similar fashion, BIOLASE Inc. posted a movement of -19.29% for the period of last 100 days, recording 14,412,002 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for BIOL is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.49.
BIOLASE Inc. (BIOL): Stocks Technical analysis and Trends
Raw Stochastic average of BIOLASE Inc. in the period of last 50 days is set at 40.95%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 82.43%. In the last 20 days, the company’s Stochastic %K was 77.14% and its Stochastic %D was recorded 76.78%.
If we look into the earlier routines of BIOLASE Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 72.47%. Additionally, trading for the stock in the period of the last six months notably improved by 141.17%, alongside a downfall of -2.73% for the period of the last 12 months. The shares increased approximately by -0.87% in the 7-day charts and went down by 14.77% in the period of the last 30 days. Common stock shares were lifted by -17.50% during last recorded quarter.